Founded Year
2005Stage
Dead | DeadTotal Raised
$64.63MAbout CeNeRx BioPharma
CeNeRx is a specialty biopharmaceutical company developing and commercializing treatments for diseases of the central nervous system (CNS). CeNeRx is developing a balanced portfolio that includes clinical-stage therapeutics for the treatment of depression, anxiety and epilepsy and a preclinical pipeline of selective cannabinoid compounds for treating pain, glaucoma and spasticity.
CeNeRx BioPharma Headquarter Location
270 Cornerstone DR Suite 103
Cary, North Carolina, 27519,
United States
919-523-0489
Latest CeNeRx BioPharma News
Dec 4, 2016
CeNeRx BioPharma, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350 02:14 EST 4 Dec 2016 | BioPortfolio Reports Home » Topics » Biotechnology Business » Latest News » CeNeRx BioPharma, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350 Summary MarketLine's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' CeNeRx BioPharma , Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments report includes business description, detailed reports on mergers and acquisitions MA, divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by CeNeRx BioPharma, Inc. since January 2007. Key Findings Provides intelligence on CeNeRx BioPharma, Inc. MA, strategic partnerships and alliances, capital raising and private equity transactions. Detailed reports of various financial transactions undertaken by CeNeRx BioPharma, Inc. and its subsidiaries since 2007. Information about key financial and legal advisors for CeNeRx BioPharma, Inc.'s financial deals transactions. Financial deals tables and charts covering deal value and volumes trend, deal types and geographybased deal activity. ReasonsToBuy Access comprehensive financial deals data along with charts and graph covering MA, private equity, and partnerships and alliances. Form an independent opinion about CeNeRx BioPharma, Inc.'s growth strategies through the organic and inorganic activities undertaken since 2007. Track your competitors' business structure and growth strategies. Related Biotechnology, Pharmaceutical and Healthcare News
Expert Collections containing CeNeRx BioPharma
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
CeNeRx BioPharma is included in 3 Expert Collections, including Pharma Startups.
Pharma Startups
6,549 items
Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.
Neuroscience
2,144 items
Companies developing products that monitor, analyze, protect, or otherwise influence the structure/function of the nervous system.
Cannabis
3,519 items
These companies participate in - or service businesses that participate in - the legal cannabis industry. Our definition of cannabis includes both marijuana and hemp (and all derivatives). The collection includes both "plant-touching" and "non-plant-touching" businesses.
CeNeRx BioPharma Patents
CeNeRx BioPharma has filed 1 patent.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
7/5/2007 | 10/12/2010 | Diffraction, Crystallography, Calorimetry, Orthorhombic minerals, Water ice | Grant |
Application Date | 7/5/2007 |
|---|---|
Grant Date | 10/12/2010 |
Title | |
Related Topics | Diffraction, Crystallography, Calorimetry, Orthorhombic minerals, Water ice |
Status | Grant |